Latest news and press releases about Bon Natural Life Limited (BON): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Bon Natural Life Limited, accompanied by its various subsidiaries, focuses on the innovation, production, and worldwide distribution of active functional compounds sourced from natural plant extracts. Its operations span the People's Republic of China and international markets. The company's diverse product range includes components for personal care items, such as plant-derived aromatic compounds supplied to manufacturers of perfumes and fragrances.
Price
| Price | $1.13 |
| Market Cap | $7M |
| Exchange | NASDAQ |
| Country | CN |
Valuation Ratios
| Price / Book | 0.05 |
| EV / EBITDA | 598.29 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -3.59% |
| Return on Invested Capital | -2.31% |
| Return on Assets | -2.34% |
| Gross Margin | 20.77% |
| Operating Margin | -8.69% |
| Net Margin | -10.68% |
Related companies: AMZE · EDBL · HCWC · IPST · MSS · NAII · PETZ
Explore sector: Basic Materials · Chemicals - Specialty
More sections of BON: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks